(Q34403833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Retargeting gene delivery using surface-engineered retroviral vector particles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

François-Loic Cosset

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

S J Russell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Biotechnology

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

461-466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

Cell targeting by murine retroviral vectors

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Modifying the host range properties of retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Retroviral retargeting by envelopes expressing an N-terminal binding domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Identification of the block in targeted retroviral-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

1 reference

7 January 2021

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Retroviral vectors displaying functional antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Functional interactions between monomers of the retroviral envelope protein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

A gene delivery system activatable by disease-associated matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Modification of retroviral tropism by display of IGF-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

In vivo selection of protease cleavage sites from retrovirus display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine le

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Modulation of phosphate uptake and amphotropic murine leukemia virus entry by posttranslational modifications of PIT-2

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Antigen-specific membrane fusion mediated by the haemagglutinin protein of influenza A virus: separation of attachment and fusion functions on different molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Antibody-directed targeting of retroviral vectors via cell surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

The plasma membrane as a combat zone in the HIV battlefield

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900246-9

7 January 2021

10.1016/S0958-1669(00)00246-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11604321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference